Form 4 for SBRA Sabra Health Care REIT, Inc.
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001862128-23-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-03-01 | SBRA | Costa Michael Lourenco | CFO, Executive VP, Sec | F - Tax | $11.80 | -5,151 | 177.2K | -3% | -$60.8K | |
| M | 2023-03-02 | 2023-02-28+ | SBRA | Costa Michael Lourenco | CFO, Executive VP, Sec | A - Grant | $0.00 | +16.8K | 182.4K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | F | D | 5,151 | $11.80 | 177,226 | D | — | — | (F3) Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. (F4) Includes 78,967 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. |
| 2 | Common | Common Stock | 2023-02-28 | A | A | 1,939 | $0.00 | 167,483 | D | — | — | (F1) Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. |
| 3 | Common | Common Stock | 2023-03-01 | A | A | 14,894 | $0.00 | 182,377 | D | — | — | (F2) Represents shares of the Issuer's Common Stock issued under the Issuer's 2009 Performance Incentive Plan subject to an annual bonus performance stock unit ("PSU") award granted on August 10, 2022, including 1,357 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on March 1, 2023 that the number of PSUs earned was 115.2% of the target. Upon this determination, the PSUs vested and were paid out immediately. Each PSU represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of an adjusted normalized funds from operations per share target for a performance period beginning January 1, 2022 and ending December 31, 2022. |